In a recent webinar, we discussed the recent increase in government enforcement against healthcare providers under the Controlled Substances Act (CSA) that has occurred over the past year.
Inside the False Claims Act, published by Bass, Berry & Sims PLC, focuses on legal developments and enforcement trends related to the False Claims Act (FCA). The blog covers topics such as healthcare fraud, procurement fraud, government investigations, whistleblower litigation, and regulatory compliance. It provides analysis of significant FCA settlements, court rulings, and government enforcement initiatives, including issues involving Medicare, Medicaid, and federal contracting. The blog also addresses related statutes like the Anti-Kickback Statute and the Eliminating Kickbacks in Recovery Act, offering insights into risk mitigation and defense strategies for companies and healthcare providers subject to FCA scrutiny.
The Department of Justice (DOJ) continues to demonstrate its sustained interest in COVID-19 relief fraud as an enforcement priority and we can expect to see persistent enforcement in this area.…
Last week, the Department of Justice (DOJ) announced a $12 million settlement with spinal device manufacturer, Innovasis Inc. (Innovasis) and senior executives Brent Felix and Garth Felix related to allegations that they violated the False Claims Act (FCA) by paying…
In a recent order denying dismissal in United States v. NH Learning Solutions Corp. (NHLS), the U.S. District Court for the Eastern District of Michigan weighed in on a False Claims Act (FCA) issue that has divided courts, ruling that…
The Department of Justice (DOJ) recently announced settlements involving alleged noncompliance with Medicare billing requirements for heart-valve replacement surgeries, false statements in federal funding research grants, and physician kickback schemes for clinical laboratories. The settlements show DOJ’s continued scrutiny in…
On May 2, the U.S. Court of Appeals for the Seventh Circuit affirmed a False Claims Act (FCA) trial verdict in part, holding that the judgment was not constitutionally excessive under the Eighth Amendment.…
Despite the recent downward trend in DOJ healthcare industry settlements, the first quarter of 2024 saw many noteworthy False Claims Act (FCA) and civil healthcare fraud settlements related to alleged kickbacks, medically unnecessary services and equipment, pharmaceutical issues and Controlled…
The United States notified the U.S. District Court for the Northern District of Georgia that it plans to intervene in a False Claims Act case filed against Georgia Tech Research Corporation (Georgia Tech) by its Associate Director of Cybersecurity and…
Bass, Berry & Sims released its 12th Annual Healthcare Fraud & Abuse Review on February 26, 2024. As a companion to the Review, we hosted a complimentary webinar which provided an overview and discussion of key focus areas covered in…